Search research articles
Contact Us
Filters
Showing results (41-50 of 80) with videos related to
Page
of 8
Sort By:
Journal of Substance Abuse Treatment
|
June 21, 2021
Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder
Jake R Morgan, Emily K Quinn, Christine E Chaisson, et al.
JAMA Network Open
|
July 12, 2022
Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use
Carl G Streed, Jake R Morgan, Mam Jarra Gai, et al.
American Journal of Obstetrics and Gynecology
|
May 25, 2022
Buprenorphine uptake during pregnancy following the 2017 guidelines update on prenatal opioid use disorder
Max Jordan Nguemeni Tiako, Angelica Meinhofer, Ari Friedman, et al.
Addiction (Abingdon, England)
|
March 19, 2021
Opioid use disorder and overdose among youth following an initial opioid prescription
Scott E Hadland, Sarah M Bagley, Mam Jarra Gai, et al.
Drug and Alcohol Dependence
|
May 29, 2021
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort
Jake R Morgan, Alexander Y Walley, Sean M Murphy, et al.
JAMA Health Forum
|
July 26, 2024
Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosis
Paul J Christine, Anna L Goldman, Jake R Morgan, et al.
JAMA Health Forum
|
November 27, 2024
Changes in Postpartum Opioid Prescribing After Implementation of State Opioid Prescribing Limits
Carrie E Fry, Alvin D Jeffery, Manuel Horta, et al.
The International Journal on Drug Policy
|
May 16, 2019
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids
Joshua A Barocas, Jake R Morgan, David A Fiellin, et al.
JAMA Network Open
|
December 15, 2020
Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting
Jake R Morgan, Joshua A Barocas, Sean M Murphy, et al.
Medical Care
|
January 13, 2022
Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design
Jake R Morgan, Emily K Quinn, Christine E Chaisson, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 80) with videos related to
Sort By:
Page
of 8
Journal of Substance Abuse Treatment
|
June 21, 2021
Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder
Jake R Morgan, Emily K Quinn, Christine E Chaisson, et al.
JAMA Network Open
|
July 12, 2022
Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use
Carl G Streed, Jake R Morgan, Mam Jarra Gai, et al.
American Journal of Obstetrics and Gynecology
|
May 25, 2022
Buprenorphine uptake during pregnancy following the 2017 guidelines update on prenatal opioid use disorder
Max Jordan Nguemeni Tiako, Angelica Meinhofer, Ari Friedman, et al.
Addiction (Abingdon, England)
|
March 19, 2021
Opioid use disorder and overdose among youth following an initial opioid prescription
Scott E Hadland, Sarah M Bagley, Mam Jarra Gai, et al.
Drug and Alcohol Dependence
|
May 29, 2021
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort
Jake R Morgan, Alexander Y Walley, Sean M Murphy, et al.
JAMA Health Forum
|
July 26, 2024
Insurance Instability for Patients With Opioid Use Disorder in the Year After Diagnosis
Paul J Christine, Anna L Goldman, Jake R Morgan, et al.
JAMA Health Forum
|
November 27, 2024
Changes in Postpartum Opioid Prescribing After Implementation of State Opioid Prescribing Limits
Carrie E Fry, Alvin D Jeffery, Manuel Horta, et al.
The International Journal on Drug Policy
|
May 16, 2019
Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids
Joshua A Barocas, Jake R Morgan, David A Fiellin, et al.
JAMA Network Open
|
December 15, 2020
Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting
Jake R Morgan, Joshua A Barocas, Sean M Murphy, et al.
Medical Care
|
January 13, 2022
Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design
Jake R Morgan, Emily K Quinn, Christine E Chaisson, et al.
Page
of 8